Targocid Injection 200mg

Manufacturer
Sanofi S.p.A.
 
Contents
Teicoplanin
 
Indication
Continuous ambulatory peritoneal dialysis (CAPD)-associated peritonitis, Complicated skin and soft tissue infections, Complicated urinary tract infections, Pneumonia, Bone and joint infections, Infective endocarditis
 
Instruction
Administer via IV infusion/IV Bolus /IM Injection
 
Drug interaction
Increased nephrotoxic effect with aminoglycosides, ciclosporin, cisplatin. Increased ototoxic effects with furosemide, ethacrynic acid.Potentially Fatal: Crossed hypersensitivity reactions with vancomycin

 Inquiry - Targocid Injection 200mg